MC not now 56m. Progress with this company still to be proven though. Remains high risk for me but still holding.
Position taken
MC 34m
Turnaround.
Historically FX pivoting to Fintech after management change a yr back.
Expanding geographically.
Director buying ✔️
Have cash and profitable.
Should be a trading update end of the month. Revenue predicted to be mid 40m.
Worth some research.
MC not now 56m. Progress with this company still to be proven though. Remains high risk for me but still holding.
A miss on TU last week with delayed roll out in Scandinavia but a huge US insurer signed up and target date for profitability retained. All US insurers previously signed have now expanding from pilots.
MC now 46m
£35m MC now after further US contract. More contract news expected before Xmas.
Worth a look. Currently £25m mc on main market. Rolling out a water leak detection device in the US. Simple business model - recurring revenue. Multiple insurers already signed with the promise of more by year end. Device production increased to 480,000/yr. $60/yr recurring revenue per device
A miss on TU last week with delayed roll out in Scandinavia but a huge US insurer signed up and target date for profitability retained. All US insurers previously signed have now expanding from pilots.
MC now 46m
SP £2.25 back in Nov when flagged. Now looking to tag £6.00.
Should be a record year for the company and a decent chance of a takeover. Otherwise Nasdaq listing in 12-18 months.
Worth some research.
SP £2.25 back in Nov when flagged. Now looking to tag £6.00.
Should be a record year for the company and a decent chance of a takeover. Otherwise Nasdaq listing in 12-18 months.
Position taken today on the drop.
168m MC. Not cheap but it looks like a quality company growing with significant further potential. I’m backing the CEO who has a significant holding.
Position taken today on the drop.
168m MC. Not cheap but it looks like a quality company growing with significant further potential. I’m backing the CEO who has a significant holding.
Position taken
MC 34m
Turnaround.
Historically FX pivoting to Fintech after management change a yr back.
Expanding geographically.
Director buying ✔️
Have cash and profitable.
Should be a trading update end of the month. Revenue predicted to be mid 40m.
Worth some research.
Position taken
MC 34m
Turnaround.
Historically FX pivoting to Fintech after management change a yr back.
Expanding geographically.
Director buying ✔️
Have cash and profitable.
Should be a trading update end of the month. Revenue predicted to be mid 40m.
Worth some research.
MC now 9.7m. Up over 200%. Uncertain it will hold without supporting contracts/NCI validation.
MC now 9.7m. Up over 200%. Uncertain it will hold without supporting contracts/NCI validation.
Significance grant news today. Derisked now. MC now 6m (3m 2 months ago).
Excellent investor meet presentation. Nano cap worth a look for those interested in recovery plays. Confident of profitability.
Significance grant news today. Derisked now. MC now 6m (3m 2 months ago).
£35m MC now after further US contract. More contract news expected before Xmas.
Worth a look. Currently £25m mc on main market. Rolling out a water leak detection device in the US. Simple business model - recurring revenue. Multiple insurers already signed with the promise of more by year end. Device production increased to 480,000/yr. $60/yr recurring revenue per device
£35m MC now after further US contract. More contract news expected before Xmas.
Worth some research.
Worth some research.
Worth some research.
Worth a look. Currently £25m mc on main market. Rolling out a water leak detection device in the US. Simple business model - recurring revenue. Multiple insurers already signed with the promise of more by year end. Device production increased to 480,000/yr. $60/yr recurring revenue per device
Worth a look. Currently £25m mc on main market. Rolling out a water leak detection device in the US. Simple business model - recurring revenue. Multiple insurers already signed with the promise of more by year end. Device production increased to 480,000/yr. $60/yr recurring revenue per device